Anthacyclines in non-small cell lung cancer

被引：0
|
作者：
Pronzato, P [1 ]
Vigani, A
Tognoni, A
Vaira, F
Canessa, P
机构：
[1] Osped S Angrea, Dept Med Oncol, I-19100 La Spezia, Italy
[2] Osped S Andrea, Dept Pneumol, I-19100 La Spezia, Italy
来源：
LUNG CANCER | 2001年 / 34卷
关键词：
non-small cell lung cancer; chemotherapy; anthracyclines;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The literature concerning the use of anthracyclines in the treatment of non-small cell lung cancer (NSCLC) is reviewed here. Overall. the activity of doxorubicin (DOXO) is unsatisfactory, whereas, the analogous epidoxorubicin (EPI) yields a 30% response rate (RR) when administered at intermediate-high doses. All active drugs, including EPI. should be considered to design the most active combination. Mainly. in the setting. in which an objective response is very important. for instance the neo-adjuvant pre-operatory setting. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：S57 / S59
页数：3
相关论文
共 50 条
  • [21] Pneumonectomy for non-small cell lung cancer
    Ichiki, Yoshinobu
    Nagashima, Akira
    Chikaishi, Yasuhiro
    Yasuda, Manabu
    SURGERY TODAY, 2012, 42 (09) : 830 - 834
  • [22] Docetaxel and non-small cell lung cancer
    Le Guen, Y
    Le Cesne, A
    BULLETIN DU CANCER, 2004, 91 (03) : 263 - 270
  • [23] Paclitaxel for non-small cell lung cancer
    Ramalingam, S
    Belani, CP
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (08) : 1771 - 1780
  • [24] Non-small cell lung cancer in the elderly
    Makrantonakis, PD
    Galani, E
    Harper, PG
    ONCOLOGIST, 2004, 9 (05): : 556 - 560
  • [25] Sorafenib in non-small cell lung cancer
    Zhang, Jianjun
    Gold, Kathryn A.
    Kim, Edward
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2012, 21 (09) : 1417 - 1426
  • [26] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    DRUGS, 2008, 68 (06) : 737 - 746
  • [27] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
  • [28] Allelotype of non-small cell lung cancer
    Neville, EM
    Stewart, MP
    Swift, A
    Liloglou, T
    Ross, H
    Gosney, JR
    Donnelly, RJ
    Field, JK
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 9 (03) : 533 - 539
  • [29] Radiotherapy of non-small cell lung cancer
    Jassem, J
    8TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2002, : 207 - 214
  • [30] Radiotherapy of non-small cell lung cancer
    Kleine, P.
    Flentje, M.
    PNEUMOLOGE, 2016, 13 (04): : 241 - +
12345